Your browser doesn't support javascript.
loading
Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia.
Eldfors, S; Kuusanmäki, H; Kontro, M; Majumder, M M; Parsons, A; Edgren, H; Pemovska, T; Kallioniemi, O; Wennerberg, K; Gökbuget, N; Burmeister, T; Porkka, K; Heckman, C A.
Afiliación
  • Eldfors S; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Kuusanmäki H; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Kontro M; Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Central Hospital Cancer Center, Helsinki, Finland.
  • Majumder MM; Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Central Hospital Cancer Center, Helsinki, Finland.
  • Parsons A; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Edgren H; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Pemovska T; MediSapiens Ltd., Helsinki, Finland.
  • Kallioniemi O; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Wennerberg K; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Gökbuget N; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Burmeister T; Department of Medicine II, Goethe University, Frankfurt, Germany.
  • Porkka K; Charité Universtätsmedizin Berlin, Med. Klinik für Hämatologie, Onkologie und Tumorimmunologie, Berlin, Germany.
  • Heckman CA; Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Central Hospital Cancer Center, Helsinki, Finland.
Leukemia ; 31(1): 51-57, 2017 01.
Article en En | MEDLINE | ID: mdl-27461063

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Purinas / Proteínas de Fusión Oncogénica / Quinazolinonas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Diagnostic_studies Límite: Adult / Humans / Male Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Finlandia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Purinas / Proteínas de Fusión Oncogénica / Quinazolinonas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Diagnostic_studies Límite: Adult / Humans / Male Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Finlandia